AntibioticDB

Highest development stage: Phase 1

Development active

Combination therapy

Mechanism of Action/Target pathogen: Complicated urinary tract infections hospital-acquired bacterial pneumonia/ ventilator-associated bacterial pneumonia

GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10874

Source: https://www.drugbank.ca/drugs/DB13090

Citation (1): https://www.ncbi.nlm.nih.gov/pubmed/28333332

Citation (2): https://aac.asm.org/content/61/5/e00072-17

Citation (3): https://www.business-standard.com/article/news-cm/wockhardt-provides-update-on-its-super-drug-antibiotic-wck-5222-117040300328_1.html

Compound/Drug Structure (2): https://www.drugbank.ca/drugs/DB01413

Zidebactam+Cefepime, WCK 5222

Drug combination: beta-lactam + beta-lactamase inhibitor

Wockhardt Ltd.